• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Infection.粪便微生物群移植对部分治疗的感染有效。
Gut Liver. 2021 Jan 15;15(1):1-2. doi: 10.5009/gnl20368.
2
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Hosts.免疫功能低下宿主艰难梭菌感染的粪便微生物群移植
Clin Infect Dis. 2021 Jun 15;72(12):2247. doi: 10.1093/cid/ciz689.
3
Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults: Treat Early, Treat Often.粪菌移植治疗高危老年患者艰难梭菌感染：尽早治疗，多次治疗。
Dig Dis Sci. 2020 Dec;65(12):3425-3427. doi: 10.1007/s10620-020-06291-6.
4
Earlier use of fecal transplant administration during hospitalization for Clostridioides difficile infectionmay improve outcome.在艰难梭菌感染住院期间更早使用粪便移植给药可能会改善治疗结果。
Eur J Gastroenterol Hepatol. 2021 Aug 1;33(8):1132-1133. doi: 10.1097/MEG.0000000000002159.
5
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.粪便微生物群移植治疗复发性艰难梭菌感染：澳大利亚的经验——有效、安全，但仍有改进空间。
Intern Med J. 2021 Jan;51(1):106-110. doi: 10.1111/imj.15162.
6
Advances in therapeutics.治疗学进展
Expert Rev Anti Infect Ther. 2021 Sep;19(9):1067-1070. doi: 10.1080/14787210.2021.1874919. Epub 2021 Jan 17.
7
Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.罗马尼亚国家指南：将与艰难梭菌感染相关的粪便微生物群移植应用转化为当地临床实践。
J Gastrointestin Liver Dis. 2021 Mar 13;30(1):147-163. doi: 10.15403/jgld-3297.
8
Fecal microbiota-based treatment for recurrent Clostridioides difficile infection.基于粪便微生物群的复发性艰难梭菌感染治疗。
Cell. 2023 Mar 16;186(6):1087. doi: 10.1016/j.cell.2023.02.034.
9
Fecal Microbiota Transplantation "Donor Effects" Are Not Clinically Relevant for Clostridioides difficile Infection.粪便微生物群移植的“供体效应”与艰难梭菌感染的临床情况无关。
Gastroenterology. 2021 Jun;160(7):2635-2636. doi: 10.1053/j.gastro.2020.12.057. Epub 2020 Dec 30.
10
Residual Gastrointestinal Symptoms after Fecal Microbiota Transplantation for Clostridioides difficile Infection: A Matter of Efficacy Rather Than Safety?艰难梭菌感染粪便微生物群移植后的残留胃肠道症状：是疗效问题而非安全性问题？
Gastroenterology. 2021 Oct;161(4):1344. doi: 10.1053/j.gastro.2021.06.002. Epub 2021 Jun 6.

引用本文的文献

1
Unveiling the hidden culprit: How the brain-gut axis fuels neuroinflammation in ischemic stroke.揭示隐藏的罪魁祸首：脑-肠轴如何引发缺血性中风中的神经炎症。
Surg Neurol Int. 2024 Nov 1;15:394. doi: 10.25259/SNI_703_2024. eCollection 2024.
2
Therapeutics involved in managing initial and recurrent infection: An updated literature review.治疗初发和复发性感染的疗法：文献综述更新
World J Gastrointest Pharmacol Ther. 2024 Sep 5;15(5):95467. doi: 10.4292/wjgpt.v15.i5.95467.
3
A Keystone Gut Bacterium -A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases.一种关键肠道细菌——肥胖及相关代谢性疾病的潜在生物治疗剂。
Foods. 2023 Jun 26;12(13):2485. doi: 10.3390/foods12132485.

本文引用的文献

1
Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Infection.与感染患者粪便微生物群移植结局相关的因素。
Gut Liver. 2021 Jan 15;15(1):61-69. doi: 10.5009/gnl20135.
2
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.COVID-19 大流行期间粪便微生物群移植服务的重组。
Gut. 2020 Sep;69(9):1555-1563. doi: 10.1136/gutjnl-2020-321829. Epub 2020 Jul 3.
3
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.粪便微生物群移植治疗复发性艰难梭菌感染：新冠疫情时代
Am J Gastroenterol. 2020 Jul;115(7):971-974. doi: 10.14309/ajg.0000000000000689.
4
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.澳大利亚共识声明：临床实践中粪便微生物群移植的监管、生产和使用。
Gut. 2020 May;69(5):801-810. doi: 10.1136/gutjnl-2019-320260. Epub 2020 Feb 11.
5
Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE).粪便微生物群移植的科学前沿：亚太消化病学会（APAGE）和亚太消化内镜学会（APSDE）联合文件。
Gut. 2020 Jan;69(1):83-91. doi: 10.1136/gutjnl-2019-319407. Epub 2019 Oct 14.
6
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
7
Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.粪便微生物群移植治疗原发性艰难梭菌感染
N Engl J Med. 2018 Jun 28;378(26):2535-2536. doi: 10.1056/NEJMc1803103. Epub 2018 Jun 2.
8
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.系统评价与荟萃分析：粪便微生物群移植治疗复发性和难治性艰难梭菌感染的疗效
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493. doi: 10.1111/apt.14201. Epub 2017 Jul 14.
9
Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.经鼻胃途径早期粪便移植显著降低艰难梭菌核糖体分型027相关死亡率：初步报告
Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1597-601. doi: 10.1007/s10096-015-2394-x. Epub 2015 May 7.

Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Infection.

作者信息

Cho Young-Seok

机构信息

Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Gut Liver. 2021 Jan 15;15(1):1-2. doi: 10.5009/gnl20368.

DOI:10.5009/gnl20368
PMID:33443235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817926/
Abstract
摘要